| Literature DB >> 32839235 |
Romain Vallion1, Jordane Divoux1, Salomé Glauzy1, Emilie Ronin1, Yannis Lombardi1, Martina Lubrano di Ricco1, Sylvie Grégoire1, Ivan Nemazanyy2, Aurélie Durand3, Delphine Fradin4, Bruno Lucas3, Benoit L Salomon5.
Abstract
CD4+ Foxp3+ regulatory T cells (Treg) are essential to maintain immune tolerance, as their loss leads to a fatal autoimmune syndrome in mice and humans. Conflicting findings have been reported concerning their metabolism. Some reports found that Treg have low mechanistic target of rapamycin (mTOR) activity and would be less dependent on this kinase compared with conventional T cells, whereas other reports suggest quite the opposite. In this study, we revisited this question by using mice that have a specific deletion of mTOR in Treg. These mice spontaneously develop a severe and systemic inflammation. We show that mTOR expression by Treg is critical for their differentiation into effector Treg and their migration into nonlymphoid tissues. We also reveal that mTOR-deficient Treg have reduced stability. This loss of Foxp3 expression is associated with partial Foxp3 DNA remethylation, which may be due to an increased activity of the glutaminolysis pathway. Thus, our work shows that mTOR is crucial for Treg differentiation, migration, and identity and that drugs targeting this metabolism pathway will impact on their biology.Entities:
Year: 2020 PMID: 32839235 DOI: 10.4049/jimmunol.1901480
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422